dc.contributor.author | Parker, C | |
dc.contributor.author | Castro, E | |
dc.contributor.author | Fizazi, K | |
dc.contributor.author | Heidenreich, A | |
dc.contributor.author | Ost, P | |
dc.contributor.author | Procopio, G | |
dc.contributor.author | Tombal, B | |
dc.contributor.author | Gillessen, S | |
dc.contributor.author | ESMO Guidelines Committee. Electronic address: [email protected] | |
dc.date.accessioned | 2021-03-01T14:31:28Z | |
dc.date.available | 2021-03-01T14:31:28Z | |
dc.identifier.citation | Annals of oncology : official journal of the European Society for Medical Oncology, 2020, 31 (9), pp. 1119 - 1134 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4376 | |
dc.identifier.eissn | 1569-8041 | |
dc.identifier.doi | 10.1016/j.annonc.2020.06.011 | |
dc.format | Print-Electronic | |
dc.format.extent | 1119 - 1134 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
dc.subject | ESMO Guidelines Committee. Electronic address: [email protected] | |
dc.subject | Humans | |
dc.subject | Prostatic Neoplasms | |
dc.subject | Prostate-Specific Antigen | |
dc.subject | Neoplasm Staging | |
dc.subject | Treatment Outcome | |
dc.subject | Radiotherapy | |
dc.subject | Follow-Up Studies | |
dc.subject | Europe | |
dc.subject | Male | |
dc.title | Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2020-06-11 | |
rioxxterms.version | AM | |
rioxxterms.versionofrecord | 10.1016/j.annonc.2020.06.011 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Annals of oncology : official journal of the European Society for Medical Oncology | |
pubs.issue | 9 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 31 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Parker, Chris | |